Despite recent advances in screening and diagnosis, tuberculosis remains the deadliest infectious disease. An estimated 10·8 ...
Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 a year in more than 100 ...
Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.
Global health groups will provide backing for two generic manufacturers to produce and distribute a low-cost version of a new ...
Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and ...
ORLANDO, Fla. — As the Trump administration works to slim down government spending, that includes millions of dollars in funding for HIV medications. LGBT+ Center Orlando was established in 1978. The ...
Advances in HIV medication, its window of detection and its transmission risk within the last decade have led to an updated ...
The WHO approves lenacapavir every six months as a new step in HIV prevention, simplifying diagnoses and expanding ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
The CDC, on behalf of the U.S. Public Health Service, has released the 2025 Guidelines for managing occupational exposure to HIV and postexposure prophylaxis (PEP), published in Infection Control & ...
World Athletics portrayed gender testing as a common-sense way to protect the female category in track and field ...
An initiative to reshape HIV care in general practice across London has been hailed a success after notable increases in HIV testing and statin prescribing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback